FRAME has appointed Dr Kate Firth, a post-doctoral research associate at the University of Lincoln within the Diabetes Research Group.
Kate first heard of FRAME when she was doing post-doctoral research at the Queen’s Medical Centre in Nottingham in the early 1990s.
“Having had first hand experience of animal research during my first degree, I moved towards alternative methods of research during my PhD and post-doctoral tenures. Becoming a trustee of FRAME will enable me to further that contribution towards the ultimate aim of the replacement of animals in medical experiments.”
Kate gained a BSc in Pharmacology followed by a PhD in Pathology. She went on to do seven years of post-doctoral research into second messenger signaling at the University of Nottingham where she developed an expertise in primary human cell culture.
She later moved into industry with Mars UK, heading up two research areas in animal nutrition.
“I would like to contribute towards an increased public profile of the work of FRAME and it’s influence on national policy making. FRAME’s work is important to me because I believe that the routine use of animals in medical experiments does not always give the best outcome or relevance. Opening the minds of scientists to alternative methods and ways of approaching the questions they are asking can only benefit us, as well as animals, in the long run.”
FRAME promotes the elimination of the need to use laboratory animals through various activities including campaigning, publication of a scientific journal (ATLA), office-based and laboratory research and through its educational work.
The aim is to work closely with corporate sponsors and to attract new ones to help them with their CSR responsibilities and to keep developing new techniques in collaboration with them.
Dr Anna Cadogan, chair of trustees at FRAME, said:
“I am delighted to welcome Kate on board. She has a clear understanding of the benefits of non-animal medical research which fits well with FRAME’s dedication to developing relevant and reliable alternatives to animal testing in medical experiments. We collaborate with industry and academia to allow us to share and access new knowledge and expertise. This sharing is crucial for discovering, developing and refining alternatives – and for promoting scientific excellence.”